About Us Locations Disclaimer

Dr. R. deGoma

Home
Prevention 2011
Who Needs Prevention
Benefits of Prevention
Risk Assessment
Advanced Lipid Therapy
Stent vs Medical Therapy
Specialized Center
Performance Data
Employer Mandate
Employee Prevention
Patient Mentoring
Coronary Calcium Score
Women & Heart Disease
NJPreventiveCardiology.com

 

Click here for NJ Preventive Cardiology practice brochure

 

Mentoring Program

The Million Hearts Initiative

For Physicians:

Practical Tips for Clinicians

For Communities:

Heart2Heart Talk

For Employers and Employees: You and Health Reform

     



 

ACCEPT Clinical System 2011


Healthcare reform and heart disease and stroke prevention are driven by data. Clinical outcomes and reduced consumption of expensive healthcare resources depend on successfully reaching treatment goals.

Drs. Rolando and Emil deGoma presented their performance data using ACCEPT system for cholesterol and cardiovascular risk management in the annual national meeting of the Society of General Internal Medicine in 2006.

Overall, 85% of high risk patients (89% of men and 78% of women) were treated of an LDL goal less than 100. This is superior to 4 other published data.

Detailed comparison of the LDL cholesterol level distribution between L-TAP study and Dr. deGoma's practice.

The difference is marked. In L-TAP only 18% (green) were treated successfully, compared to 85% using ACCEPT. ACCEPT is an acronym for A Cholesterol Clinic in Every Practice. With over 40 million high risk Americans eligible for treatment, the only way to treat such a large number to target goals is to empower all adult medical practices to become basic cholesterol clinics by educating physicians and providing them with a practical, MD-friendly, cost-effective management system.

ACCEPT System for all risk factor management - lipids, hypertension, diabetes and lifestyle modification.

Emil M. deGoma, MD, FACC

Medical Director,

UPenn Preventive Cardiovascular  Program

Health Premium Discount

Lower your risk for heart attack and stroke using evidence-based therapies and become eligible for a substantial premium discount by 2014.
Health Reform 2010
Prevention and Wellness Summary Provisions
Relay Health
Contact Office for Non-Urgent Matters

 

We Support Million Hearts Initiative

 

497,470 Preventable CHD Deaths Annually with Evidence-based Medical Therapy

 

JAMA: 38% of Nonacute Stents Called into Question

 

Optimal Medical Therapy Still Underused in CHD

 

Legacy Effects of Statin Therapy - Reduction in All-Cause Mortality

 

SG2 Expert Talks About Resetting Priorities in Cardiology

 

AHA: Get With The Guidelines - Not Much Improvement

 

AIM-HIGH Trial - Take Home Message

 

    
www.deGomaMD.com
Copyright 2001-2011     Preventing Most Heart Attacks and Strokes since 2001     eMedical Consulting     All rights reserved